A longitudinal study of changes in endometrial microvascular density in norplant® implant users
article
OA: closed
CC0
⤵ 19 in-corpus citations
AI-generated summary
This study tracked changes in endometrial microvascular density over time in women using the Norplant® implant.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study aimed to investigate the effects of the subdermal levonorgestrel contraceptive implant Norplant on endometrial vascular density at different durations of exposure, and the relationship between endometrial histology, vascular density, and bleeding patterns. A prospective controlled trial of Norplant implant users compared endometrial vascular density in biopsies taken before and after Norplant implant insertion. A total of 34 women with regular menstrual cycles requesting long-term contraception were recruited at the Sydney Centre for Reproductive Health Research, Australia. A significant increase in mean endometrial microvascular density was observed from as early as 3 weeks after insertion of Norplant implants. Vascular density was increased from a control secretory phase value of 189.6 (7.0 vessels/mm2 (+/- SEM) to 253.80 +/- 7 vessels/mm2 at 2-13 weeks of Norplant implant exposure (t ratio = 2.08, p = 0.01) and 212.7 +/- 12.9 vessels/mm2 at 14-42 weeks of exposure (t ratio = 2.03, p = 0.02). In those with atrophic endometrium, or in whom myometrium and basalis only were found in biopsies (20 of 66, 30%), mean endometrial vascular density was increased at 273.1 +/- 16.1 vessels/mm2 compared with 210.9 +/- 11.7 vessels/mm2 in other histological groups (F ratio = 9.74, p = 0.0028). Bleeding and spotting in the previous 30 days were less common in those with this histological appearance at a mean of 4.95 days compared with 8.22 days. This is the first study to assess endometrial vascular density in the early months of Norplant implant use. The findings suggest that the endometrial vasculature is profoundly altered in the early months of Norplant implant exposure when bleeding problems are most common.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Angiogenic activity of peritoneal fluid from women with endometriosis via openalex
- Dating the Endometrial Biopsy via openalex
- Uterus and endometrium: Microvascular density in conditions of endometrial atrophy via openalex
- W1965397941 via openalex
- W1975917043 via openalex
- W2003708256 via openalex
- W2018288088 via openalex
- W2025416646 via openalex
- W2039087303 via openalex
- W2055054480 via openalex
- W2057775302 via openalex
- W2099714569 via openalex
- W2141810620 via openalex
- W2149156614 via openalex
- W2262444131 via openalex
- W2262466335 via openalex
- W2270356705 via openalex
- W2276395129 via openalex
- W2288446059 via openalex
- W2299638818 via openalex
- W2305885050 via openalex
- W2418754503 via openalex
- W4238723217 via openalex
- W4239570023 via openalex
- W4285719527 via openalex
- W87202805 via openalex
- W6696193901 via openalex
- W88241752 via openalex
- W1960835072 via openalex
Cited by (19)
- In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis 2021
- Long-term progestin contraceptives (LTPOC) induce aberrant angiogenesis, oxidative stress and apoptosis in the guinea pig uterus: A model for abnormal uterine bleeding in humans 2010
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
- Endocrine Regulation of Menstruation 2005
- Endocrine Regulation of Menstruation 2005
- Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system 2004
- Effect of long-term progestin treatment on endometrial vasculature in normal cycling mice 2004
- Menstrual disorders in adolescence 2003
- Human uterine vascular structures in normal and diseased states 2003
- Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding 2003
- In-vivo angiogenesis and progestogens 2002
- Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding 2002
- Hormone replacement therapy and irregular bleeding 2001
- Hormone replacement therapy and irregular bleeding 2001
- The Clinical Relevance of Disturbances of Uterine Vascular Growth, Remodeling, and Repair 2001
- The structure of endometrial microvessels 2000
- A functional model for progestogen-induced breakthrough bleeding 2000
- Endometrial vascular changes and bleeding disturbances with long-acting progestins 2000
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK